Axonics Modulation Technologies, Inc. News Releases http://ir.axonicsmodulation.com/ Axonics Modulation Technologies, Inc. News Releases en Axonics® Announces U.S. Food & Drug Administration Approves Use of Full-Body MRI for Pivotal Study Patients http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-announces-us-food-drug-administration-approves-use-full IRVINE, Calif. --(BUSINESS WIRE)--Jun. 18, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable sacral neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , Tue, 18 Jun 2019 06:00:00 -0400 Axonics Modulation Technologies, Inc. News Releases 6981 Axonics® Announces First Quarter 2019 Financial Results and Operational Update http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-announces-first-quarter-2019-financial-results-and IRVINE, Calif. --(BUSINESS WIRE)--May 8, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable Sacral Neuromodulation (“SNM”) device for the treatment of urinary and bowel dysfunction, reported today Wed, 08 May 2019 16:00:00 -0400 Axonics Modulation Technologies, Inc. News Releases 6946 Axonics® Announces ARTISAN-SNM Pivotal Study Results Presented at the American Urological Association Annual Meeting http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-announces-artisan-snm-pivotal-study-results-presented IRVINE, Calif. --(BUSINESS WIRE)--May 6, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , Mon, 06 May 2019 09:00:00 -0400 Axonics Modulation Technologies, Inc. News Releases 6941 Axonics® to Present at Upcoming Investor Conferences http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-present-upcoming-investor-conferences IRVINE, Calif. --(BUSINESS WIRE)--May 1, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , today Wed, 01 May 2019 06:00:00 -0400 Axonics Modulation Technologies, Inc. News Releases 6936 Axonics® to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8 http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-report-first-quarter-2019-financial-results-and-host IRVINE, Calif. --(BUSINESS WIRE)--Apr. 24, 2019-- Axonics Modulation Technologies, Inc.  (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , Wed, 24 Apr 2019 06:00:00 -0400 Axonics Modulation Technologies, Inc. News Releases 6916 Axonics® Appoints Nancy L. Snyderman, M.D. and Jane E. Kiernan to its Board of Directors http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-appoints-nancy-l-snyderman-md-and-jane-e-kiernan-its IRVINE, Calif. --(BUSINESS WIRE)--Apr. 8, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , today Mon, 08 Apr 2019 06:00:00 -0400 Axonics Modulation Technologies, Inc. News Releases 6876 Axonics® to Present at the Needham Healthcare Conference http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-present-needham-healthcare-conference IRVINE, Calif. --(BUSINESS WIRE)--Apr. 2, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , Tue, 02 Apr 2019 06:00:00 -0400 Axonics Modulation Technologies, Inc. News Releases 6871 Axonics® to Participate in Upcoming Investor Events http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-participate-upcoming-investor-events IRVINE, Calif. --(BUSINESS WIRE)--Mar. 7, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , Thu, 07 Mar 2019 06:00:00 -0500 Axonics Modulation Technologies, Inc. News Releases 6861 Axonics® Announces Fourth Quarter and Full Year 2018 Financial Results and Operational Update http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-announces-fourth-quarter-and-full-year-2018-financial IRVINE, Calif. --(BUSINESS WIRE)--Mar. 5, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , Tue, 05 Mar 2019 16:00:00 -0500 Axonics Modulation Technologies, Inc. News Releases 6831 Axonics® Appoints Michael H. Carrel to its Board of Directors http://ir.axonicsmodulation.com/news-releases/news-release-details/axonicsr-appoints-michael-h-carrel-its-board-directors IRVINE, Calif. --(BUSINESS WIRE)--Mar. 4, 2019-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of  urinary and bowel dysfunction , today Mon, 04 Mar 2019 06:00:00 -0500 Axonics Modulation Technologies, Inc. News Releases 6821